Merck Drops 2030 Sales Target For Gardasil As China Slump Continues
Significant Tariff Impact Is Unlikely
The drug maker withdrew its goal of $11bn in sales for the HPV vaccine and paused shipments to China so that partner Zhifei can reduce its inventory.
